Top Companies in the Suppositories

The global suppositories market is projected to reach USD 2.05 billion by 2030 from USD 1.63 billion in 2025, at a CAGR of 4.7% during the forecast period. The growing prevalence of gastrointestinal disorders and rectal diseases, coupled with the rising elderly population and increasing preference for localized drug delivery, are expected to drive the demand for suppositories globally. However, stringent regulatory standards across regions and patient discomfort and stigma, with suppository usage, may hinder the market growth.

Some of the prominent players operating in the market include Bayer AG (Germany), Novartis AG (Switzerland), Sanofi (France), Zydus Group (India), Bliss GVS Pharma Limited (India), Church & Dwight Co., Inc. (US), Bausch Health Companies Inc. (Canada), Teva Pharmaceutical Industries Ltd. (Israel), Sun Pharmaceutical Industries Ltd. (India), Adcock Ingram (South Africa), Aspen Holdings (South Africa), Julphar (UAE), Cipla (India), Haleon Group of Companies (UK), and Prestige Consumer Healthcare (US).

• In October 2024, Sanofi (France) partnered with Opella Healthcare Group SAS (France) to form an independent Consumer Healthcare company through a 50:50 joint venture with Clayton, Dubilier & Rice (CD&R). The new entity, Opella Healthcare Group, will allow more focused growth of OTC brands like Dulcoflex. Sanofi retains a 48.2% stake, enabling strategic oversight while allowing Opella full operational independence.

To know about the assumptions considered for the study download the pdf brochure

Bayer AG (Germany)

Bayer is a global life sciences company that operates through three business segments: Pharmaceuticals, Consumer Health, and Crop Science. Through its consumer health segment, the company offers over-the-counter (OTC) medicines with a broad portfolio of products that support self-medication and self-care, which includes suppositories for the treatment of internal hemorrhoids (piles) and local anesthetics.

Bayer operates in over 80 countries and has a robust presence across Europe, North America, Asia-Pacific, and Latin America. In May 2023, the company launched a new business unit in the US that focused on developing precision health consumer products. This initiative aimed to leverage data science, genetics, and digital technologies to create personalized, science-based solutions in areas such as pain management, digestive health, and dermatology, reinforcing Bayer’s leadership in the self-care market. Its subsidiaries include Bayer Material Science (Germany), Bayer Schering Pharma AG (Germany), Bayer Crop Science (India), Bayer HealthCare (Germany), Bayer Technology Services (Germany), Bayer HealthCare Pharmaceuticals (Germany), and Bayer Chemicals (Germany).

Novartis AG (Switzerland)

Novartis is one of the leading market players specializing in innovative prescription medicines, followed by the spin-off of its generics and biosimilars business (Sandoz) in 2023. The company operates as a single global segment that conducts R&D, manufactures, distributes, commercializes, and sells innovative medicines. This business segment operates globally through core therapeutic areas such as cardiovascular, renal, metabolic, immunology, neuroscience, oncology, and established brands. The company provides suppositories through its established brands segment.

The company researches various disease areas through the Novartis Institutes for BioMedical Research (NIBR) and operates through a network of subsidiaries and offices in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Sanofi (France)

Sanofi is one of the global healthcare leaders engaged in the manufacture, R&D, and commercialization of therapeutic solutions. The company operates mainly through two business segments: Biopharma and Consumer Healthcare.

The Consumer Healthcare segment was previously integrated within Sanofi but was reconstructed into an independently operated company named Opella Healthcare Group. In April 2025, Sanofi sold a 50% stake in Opella to Clayton, Dubilier & Rice (CD&R), a global investment firm, while retaining a 48.2% equity interest. Opella now functions as one of the standalone global leaders in over-the-counter (OTC) consumer health products, with a portfolio including trusted brands in digestive health, pain relief, allergy, and personal care. Through Opella, Sanofi continues to offer suppositories as part of its digestive health segment.

Sanofi operates nearly 100 manufacturing sites across 41 countries and delivers healthcare solutions in over 170 countries. Key subsidiaries include Sanofi Pasteur (France), Sanofi Genzyme (US), Shantha Biotechnics (India), Chattem Healthcare (US), Ablynx (Belgium), Sanofi México, Sanofi Medley Farmacêutica (Brazil), and others across Vietnam, Australia, and India.

Market Ranking

The global suppositories market is fragmented in nature, with the top players being GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Baxter (US), FUKUDA DENSHI (Japan), Shenzhen Mindray Bio-Medical Electronics (China), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), and Bittium (Finland). The competition among the leading players is high, and most focus on establishing partnerships with others to ensure a stable market share. The market is dominated by key players with a strong global footprint and well-established supply and distribution chains in developed regions such as North America and Europe. Smaller players strive for sustainable growth by focusing on low-price products and technological innovation. This results in a highly competitive market with numerous small and medium-sized players in developed and emerging economies. Meanwhile, the dominant market players leverage their expertise, higher R&D budgets, and strong brand recognition to minimize competition from smaller players in regional markets.

Related Reports:

Suppositories Market by Type (Urethral, Rectal, Vaginal), Base (Oleaginous, Aqueous, Emulsifying), Prescription (OTC, Prescribed), Application (Analgesic, Laxatives, Anti-fungal, Nasal Decongestants), Patient (Adult & Pediatrics) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com